| Issue Date | Title | Author(s) |
| 2018 | A novel polymorphism in the promoter of the CYP4A11 gene is associated with susceptibility to coronary artery disease | Sirotina, S.; Ponomarenko, I.; Kharchenko, A.; Bykanova, M.; Churnosov, M. |
| 2023 | Lipid-Associated GWAS Loci Predict Antiatherogenic Effects of Rosuvastatin in Patients with Coronary Artery Disease | Kononov, S.; Azarova, L.; Klyosova, E.; Bykanova, M.; Churnosov, M. |
| 2022 | Pharmacogenetic loci for rosuvastatin are associated with intima-media thickness change and coronary artery disease risk | Kononova, S.; Mal, G.; Azarova, I.; Klyosova, E.; Bykanova, M.; Churnosov, M.; Polonikov, A. |
| 2017 | Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population | Polonikov, A.; Kharchenko, A.; Bykanova, M.; Sirotina, S.; Ponomarenko, I. |
| 2017 | Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population | Polonikov, A.; Kharchenko, A.; Bykanova, M.; Sirotina, S.; Churnosov, M. |
| 2017 | The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population | Polonikov, A.; Bykanova, M.; Ponomarenko, I.; Sirotina, S.; Bocharova, A. |
